Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
RUNX1C isoform identified as driver of chemoresistance in acute myeloid leukemia

RUNX1C isoform identified as driver of chemoresistance in acute myeloid leukemia

Dual epigenetic marks found to regulate cell identity

Dual epigenetic marks found to regulate cell identity

Cancer cells hide inside bone marrow fibroblasts to resist treatment

Cancer cells hide inside bone marrow fibroblasts to resist treatment

Nudibranchs (sea slugs) emerge as a promising source of cancer drugs

Nudibranchs (sea slugs) emerge as a promising source of cancer drugs

Research finds long-term health challenges in survivors of childhood cancer

Research finds long-term health challenges in survivors of childhood cancer

Many patients with high-risk myelodysplastic syndromes do not receive guideline-recommended treatment

Many patients with high-risk myelodysplastic syndromes do not receive guideline-recommended treatment

Immunoglobulin replacement therapy not associated with reduced risk of serious infections in patients with CLL

Immunoglobulin replacement therapy not associated with reduced risk of serious infections in patients with CLL

Immunotherapy shows promise in changing leukemia’s cellular environment

Immunotherapy shows promise in changing leukemia’s cellular environment

Discovery of TAF1's role could revolutionize cancer treatment

Discovery of TAF1's role could revolutionize cancer treatment

Deep-sea bacterial compound triggers pyroptosis to fight cancer

Deep-sea bacterial compound triggers pyroptosis to fight cancer

Australian study uncovers first potential prophylactic treatment against HTLV-1

Australian study uncovers first potential prophylactic treatment against HTLV-1

CRISPR-mediated DNA methylation editing regulates inflammation and tumor growth

CRISPR-mediated DNA methylation editing regulates inflammation and tumor growth

Nuclear waste exposure in childhood associated with higher cancer incidence

Nuclear waste exposure in childhood associated with higher cancer incidence

People with Chronic Lymphocytic Leukemia benefit from exercise yet lack personalized guidance

People with Chronic Lymphocytic Leukemia benefit from exercise yet lack personalized guidance

New approach makes mismatched stem cell transplants safer for blood cancer patients

New approach makes mismatched stem cell transplants safer for blood cancer patients

Mapping the metabolic journey of blood stem cells

Mapping the metabolic journey of blood stem cells

Acromegaly linked to higher cancer risk

Acromegaly linked to higher cancer risk

Early-career physician-scientists receive major support from Damon Runyon Cancer Research Foundation

Early-career physician-scientists receive major support from Damon Runyon Cancer Research Foundation

New immunotherapy targets leukemia at its root

New immunotherapy targets leukemia at its root

Uncovering the hidden architecture of the genome in three dimensions

Uncovering the hidden architecture of the genome in three dimensions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.